INSTALL THE ELECTRIC PEPTIDES APP
PRICE PER VIAL
$60.00
IN STOCK
SIZE
QTY
1
= $60.00PAYMENT DETAILS PROVIDED AFTER INQUIRY SUBMISSION
METABOLIC
Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for metabolic regulation, glucose control, and body composition research.
TECHNICAL SPECIFICATIONS
PURITY
99.5%
STORAGE
Lyophilized: -20°C. Reconstituted: 2–8°C, use within 28 days.
RESEARCH APPLICATIONS
Metabolic syndrome
Glucose regulation
GLP-1/GIP receptor activity
Body composition research
Insulin sensitivity
RESEARCH PROFILE
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It activates both incretin hormone receptors simultaneously, producing synergistic effects on insulin secretion, glucagon suppression, and appetite regulation. Ongoing research investigates its role in metabolic syndrome, type 2 diabetes models, and adipose tissue reduction.
DISCLAIMER: THIS PRODUCT IS SOLD FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION. THE BUYER ASSUMES ALL RESPONSIBILITY FOR THE USE OF THIS PRODUCT.